I’m long CRMD thanks, to a CTSO mod.
Also, I am a former “Professional” options trader. Lol. Also, just yesterday, !, I turned a roughly 40K profit into a roughly 10k loss, (CTSO Aug 12.5 calls). Those are my bonafides, lol.
Okay. Long winded post........quiet Saturday.....
Ok. Think of it like any other “option”, to buy something, like a real estate contract, where you obtain an ‘option’ to buy (but not an obligation), If you are a BUYER of a call option.
So, a Call option, if you BUY it, gives you the right, but not the obligation, to purchase the stock (CRMD, the underlying), at a set price, within a determined time frame. The right/Not the obligation. Example CRMD Mar 2.5’s (btw, I bot 600 of em, at .10 / fingers crossed). So. Each one represents the right (YOU are not obliged) to buy 100 shares of the underlying, at whatever “strike price” , in this case 2.5. So let’s say you buy 100 CRMD Mar 2.5’s. You pay .10. You really paid $1,000, for the right, but not the obligation, to buy 10,000 shares of CRMD, at 2.5 dollars a share, anytime between now and the 3rd Friday in March. Remember, each call really represents 100 shares of stock. So, the. 10 cents for each is really 10 bucks, each (out of your pocket). You’ll never really (almost ever) literally exercise that right....The Calls will always trade (9 variables go into the pricing of an option/don’t worry about it) in the options market/secondary market. So, you bought one hundred, at a dime, ($1,000 to you; 100 times ten bucks) and Celgene buys out CRMD for 4 bucks a share.!!! Those 2.5 calls will have an INTRINSIC value of 1.5, (2.5 plus 1.5 =4), or 150 bucks each. You’ll simply sell them back into the (secondary) options market, (probably the bid ask will be about 1.4 Bid and 1.6 Ask, (cause the market makers want to lock up some profits). So, in theory, if you sell em at their intrinsic value of 1.5, you’ll have turned $1,000 into $15,000. Sounds easy. (you will also miss out on all price moves from .63 to 2.5.... which is why Lazer wants 1 or 1.5 strikes). Or just buy the stock, capture the full move, and also you don’t worry about the decaying time value of an option. They are worth ZERO if CRMD is below 2.5 third Friday in March. I will lose 6K, if so. Good news, you can only lose all you spent....As a BUYER.
So, if you’re still with me.... just FYI, the folks that SELL you the call option, they just entered into a legally binding contract (option “contracts”! Ah!) to deliver/sell to you/the buyer CRMD shares, at the “strike price” or “contract” price, of $2.5 dollars a share....even though the stock is now trading at 4. Lots of leverage if you’re right. Not easy being right. Smart folks tend to sell calls, with fat “premiums” , or excess over intrinsic values (based on those 9 variables) , against stock they own. It called a Covered Write. Or a Buy Write. Google that one. There is only .10 cent premium in these. Clearly the “market” is not expecting this. Hope I gave you something. I’m swinging for a buy out. I also bought the stock, fwiw. Thank you and Lazer for your dialogue. Sorry to make you read, hope there is something somewhere in this mess.
Recent CRMD News
- CorMedix Inc. Receives FDA Feedback on Potential Label Expansion • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath • GlobeNewswire Inc. • 06/06/2024 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/23/2024 04:15:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:22:51 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/09/2024 09:06:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 12:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:40:17 AM
- CorMedix Inc. Announces CMS Grants TDAPA to DefenCath • GlobeNewswire Inc. • 04/19/2024 12:30:00 PM
- CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin) • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/12/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 10:26:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 01:11:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 01:10:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 01:09:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 01:04:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 01:39:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:05:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:11:33 PM
- CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/14/2023 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:35:11 PM
- CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek Conference • GlobeNewswire Inc. • 10/11/2023 12:30:00 PM
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM